Unaudited Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2026	Sep. 30, 2025
Cash flows from operating activities:
Net loss	$ (125,311)	$ (101,549)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization	17,957	7,964
Stock-based compensation	109,515	97,664
Amortization of deferred commissions	47,861	38,958
Non-cash operating lease costs	8,214	7,442
Amortization of debt issuance costs	1,533	2,471
Amortization of premium and accretion of discount on marketable securities, net	1,980	1,211
Deferred income taxes, net	(9,652)	0
Remeasurement of options to repurchase common stock	2,091	0
Changes in assets and liabilities:
Accounts receivable	75,784	46,534
Prepaid expenses and other short-term assets	21,213	4,208
Deferred commissions	(72,353)	(57,731)
Other long-term assets	(7,028)	(279)
Trade payables	2,941	755
Accrued expenses and other short-term liabilities	32,400	23,420
Deferred revenues	(3,226)	50,104
Other long-term liabilities	4,377	1,575
Net cash provided by operating activities	108,296	122,747
Cash flows from investing activities:
Proceeds from maturities of marketable securities	329,645	324,080
Proceeds from sales of marketable securities	211,585	0
Investment in marketable securities	(309,477)	(229,446)
Proceeds from short-term and long-term deposits	167,477	159,405
Investment in short-term and long-term deposits	(167,454)	(156,089)
Acquisitions, net of cash acquired	(113,622)	(123,514)
Purchases of property and equipment	(10,906)	(8,687)
Capitalized internal-use software	(2,620)	(2,509)
Net cash provided by (used in) investing activities	104,628	(36,760)
Cash flows from financing activities:
Repurchase of common stock	(135,000)	(100,000)
Payment of deferred consideration for acquisition	(3,502)	0
Proceeds from options to repurchase common stock	2,900	0
Proceeds from employee stock plans	13,997	14,349
Taxes paid related to net share settlement of equity awards	(22,847)	(28,430)
Repayment of convertible senior notes	0	(137)
Net cash used in financing activities	(144,452)	(114,218)
Increase (decrease) in cash and cash equivalents	68,472	(28,231)
Cash and cash equivalents at beginning of period	202,482	185,585
Cash and cash equivalents at end of period	270,954	157,354
Supplemental disclosure of cash flow information:
Cash refunded for income taxes	(20,751)
Cash paid for income taxes		6,825
Cash paid for interest	4,603	7,719
Supplemental disclosure of non-cash activities:
Lease liabilities arising from obtaining right-of-use assets	9,408	19,064
Liability related to acquisition holdback	0	3,502
Common stock issued for debt conversion	$ 0	$ 251,439